title: The impact of the bundle on lab services.
abstract: The rule states that CMS will implement a quality incentive program (QIP) for Medicare outpatient end-stage renal disease (ESRD) dialysis providers and facilities with payment consequences beginning January 1, 2012. This is in accordance with section 1881(h) of the Act (added on July 15, 2008 by section 153(c) of the Medicare Improvements for Patients and Providers Act (MIPPA)). Under the ESRD QIP, ESRD payments made to dialysis providers and facilities under section 1881(b)(14) of the Social Security Act will be reduced by up to 2% if the providers/facilities fail to meet or exceed a total performance score for standards related to certain specified performance measures.
authors.affiliation: RenalLabs, Jackson, Miss., USA .
authors.forename: Mike
authors.initials: M
authors.lastname: Burney
mesh_terms: D003955:Diagnostic Tests, Routine / Q000191:economics*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D006278:Medicare / Q000191:economics*; D011445:Prospective Payment System; D006435:Renal Dialysis / Q000191:economics*; D014481:United States